Navigation Links
OCT - Optical Coherence Tomography - the buzzword in cardiology

The latest in cardiology is OCT, which expands into Optical Coherence Tomography. This breakthrough has made many cardiologists sit up and take notice and is revolutionizing angioplasty. This has been developed by Dr. Brett Bouma an assistant professor at Harvard Medical School who has used optical coherence tomography to gauge stent status.//

This is a new imaging technique similar to ultrasound and will allow cardiologists to view the status of coronary stents used to open clogged arteries during angioplasty. A more glamorous way of putting it would be to say that this was the procedure that the new American Vice President Dick Cheney underwent.

During angioplasty, a tiny balloon is inflated inside a mesh tube placed within a blocked artery, gradually opening the vessel. However in about 30 percent of patients tissue often grows back, either inside or at either end of the stent, a problem known as restenosis.

Stent angioplasty is performed on nearly 500,000 patients each year. Until now, there has been little ability during, or following the procedure, to accurately monitor how the stents were being deployed.

With this new technique now available, interventional cardiologists will find it easier to perform angioplasties in even completely clogged vessels, thereby bringing cheer and hope to millions around the world.


'"/>




Page: 1

Related medicine news :

1. Optical Imaging Added To Ultrasound To Improve Imaging Of Breast Cancer
2. Horse Heart Coherence May Be Key To Non-invasive Stress Detection
3. Predicting Severity Of Appendicitis With Computed Tomography
4. Madras Medical College to have a Centre for preventive cardiology
Post Your Comments:
Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands Free System 14040 1ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands Free System 14040 2ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands Free System 14040 3ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands Free System 14040 4Clalit Health Services Installs DBSophic 26apos 3Bs Database Performance Optimization Solution 57144 1Clalit Health Services Installs DBSophic 26apos 3Bs Database Performance Optimization Solution 57144 2Clalit Health Services Installs DBSophic 26apos 3Bs Database Performance Optimization Solution 57144 3Clalit Health Services Installs DBSophic 26apos 3Bs Database Performance Optimization Solution 57144 4STEMCELL Technologies Applauds Feeder free Derivation of Human Induced Pluripotent Stem Cells 57142 1STEMCELL Technologies Applauds Feeder free Derivation of Human Induced Pluripotent Stem Cells 57142 2